Cargando…
244 : Homologous 2′,5′-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity
Efficient and productive virus infection often requires viral countermeasures that block innate immunity. The interferon-inducible 2′,5-oligoadenylate (2-5A) synthetases (OAS) and ribonuclease L (RNase L) are components of a potent host antiviral pathway. We previously showed that murine coronavirus...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129772/ http://dx.doi.org/10.1016/j.cyto.2013.06.247 |
_version_ | 1783516860945268736 |
---|---|
author | Silverman, Robert H. Zhang, Rong Jha, Babal K. Ogden, Kristen M. Dong, Beihua Elliott, Ruth Zhao, Ling Patton, John T. Weiss, Susan R. |
author_facet | Silverman, Robert H. Zhang, Rong Jha, Babal K. Ogden, Kristen M. Dong, Beihua Elliott, Ruth Zhao, Ling Patton, John T. Weiss, Susan R. |
author_sort | Silverman, Robert H. |
collection | PubMed |
description | Efficient and productive virus infection often requires viral countermeasures that block innate immunity. The interferon-inducible 2′,5-oligoadenylate (2-5A) synthetases (OAS) and ribonuclease L (RNase L) are components of a potent host antiviral pathway. We previously showed that murine coronavirus (MHV) accessory protein ns2, a 2H phosphoesterase superfamily member, is a phosphodiesterase (PDE) that cleaves 2′,5′-oligoadenylates (2-5A) thereby preventing activation of RNase L (Zhao et al., Cell Host and Microbe 11:607–16, 2012). The PDE activity of ns2 is required for viral replication in macrophages and for hepatitis. Here, we will demonstrate that group A rotavirus, the primary cause of severe, dehydrating gastroenteritis in children worldwide, encodes an homologous and similar PDE. The VP3 carboxy-terminal domain (VP3-CTD) shares sequence and predicted structural homology with ns2, including two catalytic His-x-Thr/Ser motifs. Recombinant VP3-CTD also demonstrated 2′,5′-PDE activity, which cleaved 2-5A in vitro. In addition, its expression in cells depleted 2-5A levels induced by OAS activation with poly (rI):poly (rC), preventing RNase L activation. In the context of recombinant chimeric MHV expressing inactive ns2, the VP3-CTD restored the ability to replicate efficiently in macrophages or in the livers of infected mice, while chimeras expressing inactive VP3-CTD (H718A or H798R) were attenuated. Also, chimeric viruses expressing active ns2 or VP3, but not mutant ns2 or VP3, were able to protect ribosomal RNA from RNase L-mediated degradation. Thus, VP3-CTD is a 2′,5′-PDE able to functionally substitute for ns2 in the context of MHV infection. Remarkably, therefore, two disparate RNA viruses encode proteins with homologous 2′,5′-PDEs that antagonize innate immunity. In addition, based on sequence and predicted structural homology with MHV ns2 and rotavirus VP3, several other viruses have been identified that encode proteins with predicted 2′,5′-PDE activities. |
format | Online Article Text |
id | pubmed-7129772 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71297722020-04-08 244 : Homologous 2′,5′-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity Silverman, Robert H. Zhang, Rong Jha, Babal K. Ogden, Kristen M. Dong, Beihua Elliott, Ruth Zhao, Ling Patton, John T. Weiss, Susan R. Cytokine Article Efficient and productive virus infection often requires viral countermeasures that block innate immunity. The interferon-inducible 2′,5-oligoadenylate (2-5A) synthetases (OAS) and ribonuclease L (RNase L) are components of a potent host antiviral pathway. We previously showed that murine coronavirus (MHV) accessory protein ns2, a 2H phosphoesterase superfamily member, is a phosphodiesterase (PDE) that cleaves 2′,5′-oligoadenylates (2-5A) thereby preventing activation of RNase L (Zhao et al., Cell Host and Microbe 11:607–16, 2012). The PDE activity of ns2 is required for viral replication in macrophages and for hepatitis. Here, we will demonstrate that group A rotavirus, the primary cause of severe, dehydrating gastroenteritis in children worldwide, encodes an homologous and similar PDE. The VP3 carboxy-terminal domain (VP3-CTD) shares sequence and predicted structural homology with ns2, including two catalytic His-x-Thr/Ser motifs. Recombinant VP3-CTD also demonstrated 2′,5′-PDE activity, which cleaved 2-5A in vitro. In addition, its expression in cells depleted 2-5A levels induced by OAS activation with poly (rI):poly (rC), preventing RNase L activation. In the context of recombinant chimeric MHV expressing inactive ns2, the VP3-CTD restored the ability to replicate efficiently in macrophages or in the livers of infected mice, while chimeras expressing inactive VP3-CTD (H718A or H798R) were attenuated. Also, chimeric viruses expressing active ns2 or VP3, but not mutant ns2 or VP3, were able to protect ribosomal RNA from RNase L-mediated degradation. Thus, VP3-CTD is a 2′,5′-PDE able to functionally substitute for ns2 in the context of MHV infection. Remarkably, therefore, two disparate RNA viruses encode proteins with homologous 2′,5′-PDEs that antagonize innate immunity. In addition, based on sequence and predicted structural homology with MHV ns2 and rotavirus VP3, several other viruses have been identified that encode proteins with predicted 2′,5′-PDE activities. Published by Elsevier Ltd. 2013-09 2013-08-14 /pmc/articles/PMC7129772/ http://dx.doi.org/10.1016/j.cyto.2013.06.247 Text en Copyright © 2013 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Silverman, Robert H. Zhang, Rong Jha, Babal K. Ogden, Kristen M. Dong, Beihua Elliott, Ruth Zhao, Ling Patton, John T. Weiss, Susan R. 244 : Homologous 2′,5′-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity |
title | 244 : Homologous 2′,5′-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity |
title_full | 244 : Homologous 2′,5′-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity |
title_fullStr | 244 : Homologous 2′,5′-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity |
title_full_unstemmed | 244 : Homologous 2′,5′-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity |
title_short | 244 : Homologous 2′,5′-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity |
title_sort | 244 : homologous 2′,5′-phosphodiesterases from disparate rna viruses antagonize antiviral innate immunity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129772/ http://dx.doi.org/10.1016/j.cyto.2013.06.247 |
work_keys_str_mv | AT silvermanroberth 244homologous25phosphodiesterasesfromdisparaternavirusesantagonizeantiviralinnateimmunity AT zhangrong 244homologous25phosphodiesterasesfromdisparaternavirusesantagonizeantiviralinnateimmunity AT jhababalk 244homologous25phosphodiesterasesfromdisparaternavirusesantagonizeantiviralinnateimmunity AT ogdenkristenm 244homologous25phosphodiesterasesfromdisparaternavirusesantagonizeantiviralinnateimmunity AT dongbeihua 244homologous25phosphodiesterasesfromdisparaternavirusesantagonizeantiviralinnateimmunity AT elliottruth 244homologous25phosphodiesterasesfromdisparaternavirusesantagonizeantiviralinnateimmunity AT zhaoling 244homologous25phosphodiesterasesfromdisparaternavirusesantagonizeantiviralinnateimmunity AT pattonjohnt 244homologous25phosphodiesterasesfromdisparaternavirusesantagonizeantiviralinnateimmunity AT weisssusanr 244homologous25phosphodiesterasesfromdisparaternavirusesantagonizeantiviralinnateimmunity |